Chr. Hansen GmbH
Improving food and health
Building on more than 145 years of research in microbial science,
we use nature’s own resources to commercialize innovations from
farm to fork, for the benefit of animals, plants and humans – and
today more than 1 billion people consume one of our ingredients
every day. Our technological platform has game-changing potential
For more information: www.chr-hansen.com
8
and is more relevant today than ever before. We use this
unique position to drive a sustainable food and health revolution,
together with our partners and customers.
Chr. Hansen was founded in 1874 by a young, ambitious pharmacist
in the capital of Denmark, Copenhagen. His name was Christian
Ditlev Ammentorp Hansen, and he was about to make a fundamental
impact on the history of science and innovation in the food
industry.
Based on Christian D.A. Hansen’s legacy and our desire to explore
the unknown, Chr. Hansen has continued to develop natural and
microbial solutions for future generations and has grown to become
a pioneer and market leader within our core business areas:
Food Cultures & Enzymes and Health & Nutrition. With our innovation
as the backbone we have made it our mission to improve
food and health by working with nature’s resources to develop
sustainable solutions for the food, nutritional, pharmaceutical and
agricultural industries.
Production takes place at state-of-the-art facilities on four continents,
which all share ambitious goals to continuously improve
our performance on environment, climate and occupational health
and safety.
Chr. Hansen Germany
Technology center in Pohlheim and Nienburg
Chr. Hansen has been active in Germany for more than 90 years, an
important market for the company. Pohlheim is our global center
of excellence for meat cultures, bioprotection as well as cultures
for non-alcoholic beer and fermented beverages. Since the site
has become part of Chr. Hansen in 1991, it has been extended
continuously with the latest significant expansion including new
logistic (2018) and QC facilities (2020). More than 100 passionated
employees work in innovation, production, logistics and support
functions by dedicated teamwork along the value chain, to secure
first class supply of our customers worldwide and day by day.
In September 1997 Chr. Hansen acquired fermentation facilities
for the production of enzymes in Nienburg/Weser. Since then,
chymosin, an enzyme for cheese production, has been produced in
a modern biotechnological fermentation process. Chr. Hansen sells
/www.chr-hansen.com
/www.chr-hansen.com
